9.2 time-series forecasting procedure Search Results


94
MedChemExpress protein kinase c pkc inhibitors
Expression of MMP9 in IL-8 treated HCCLM6 cells. (A) Relative mRNA expression of MMP9. (B) Relative protein expression levels of MMP9 in IL-8 treated HCCLM6 cells. (C) Western blots show phosphorylated <t>PKC,</t> phosphorylated ERK1/2, and total proteins of PKC or ERK1/2 at the indicated times. α-tubulin was used as a loading control. (D) The PKC inhibitor chelerythrine chloride (20 µM) and ERK1/2 inhibitor PD98059 (40 µM) significantly decreased the mRNA levels of MMP9 in IL-8-treated HCCLM6 cells. (E) Western blot assay was used to assess the protein expression levels of MMP9 in IL-8-treated HCCLM6 cells. The data are presented as mean ± SD. *, P<0.05; **, P<0.01, compared with the blank group. MMP9, matrix metallopeptidase 9; IL-8, interleukin-8; HCCLM6, hepatocellular carcinoma LM6; PKC, protein kinase C; ERK1/2, extracellular regulated protein kinases 1/2; SD, standard deviation.
Protein Kinase C Pkc Inhibitors, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/9%2E2+time-series+forecasting+procedure/Chelerythrine+chloride/pmc09560869-43-5-11
Average 94 stars, based on 1 article reviews
protein kinase c pkc inhibitors - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

87
Thermo Fisher gene exp tgfbr1 hs00610318 m1
A and B, Activin and myostatin levels of mRNA expression in eight paired fibroid and myometrial specimens. C–F, Levels of mRNA expression in eight paired fibroid and myometrial specimens for the four receptor genes ALK4, <t>ALK5,</t> ActRII, and ActRIIB. Graphs on column I are line graphs linking paired specimens, and those on column II are box-and-whisker plots. In column III is reported the correlation of activin-A with its receptors, whereas in column IV is reported the correlation of myostatin with its receptors. The nonparametric correlation (Spearman) revealed no correlation of both activin and myostatin levels with receptor levels. *, P < 0.05.
Gene Exp Tgfbr1 Hs00610318 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 87/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/9%2E2+time-series+forecasting+procedure/Gene+Exp%2E+TGFBR1%2C+Hs00610318_m1/pmc03047220-209-109-184
Average 87 stars, based on 1 article reviews
gene exp tgfbr1 hs00610318 m1 - by Bioz Stars, 2026-09
87/100 stars
  Buy from Supplier

Image Search Results


Expression of MMP9 in IL-8 treated HCCLM6 cells. (A) Relative mRNA expression of MMP9. (B) Relative protein expression levels of MMP9 in IL-8 treated HCCLM6 cells. (C) Western blots show phosphorylated PKC, phosphorylated ERK1/2, and total proteins of PKC or ERK1/2 at the indicated times. α-tubulin was used as a loading control. (D) The PKC inhibitor chelerythrine chloride (20 µM) and ERK1/2 inhibitor PD98059 (40 µM) significantly decreased the mRNA levels of MMP9 in IL-8-treated HCCLM6 cells. (E) Western blot assay was used to assess the protein expression levels of MMP9 in IL-8-treated HCCLM6 cells. The data are presented as mean ± SD. *, P<0.05; **, P<0.01, compared with the blank group. MMP9, matrix metallopeptidase 9; IL-8, interleukin-8; HCCLM6, hepatocellular carcinoma LM6; PKC, protein kinase C; ERK1/2, extracellular regulated protein kinases 1/2; SD, standard deviation.

Journal: Translational Cancer Research

Article Title: Effect of IL-8 on hepatocellular carcinoma-associated metastasis by targeting MMP9 in mice

doi: 10.21037/tcr-22-37

Figure Lengend Snippet: Expression of MMP9 in IL-8 treated HCCLM6 cells. (A) Relative mRNA expression of MMP9. (B) Relative protein expression levels of MMP9 in IL-8 treated HCCLM6 cells. (C) Western blots show phosphorylated PKC, phosphorylated ERK1/2, and total proteins of PKC or ERK1/2 at the indicated times. α-tubulin was used as a loading control. (D) The PKC inhibitor chelerythrine chloride (20 µM) and ERK1/2 inhibitor PD98059 (40 µM) significantly decreased the mRNA levels of MMP9 in IL-8-treated HCCLM6 cells. (E) Western blot assay was used to assess the protein expression levels of MMP9 in IL-8-treated HCCLM6 cells. The data are presented as mean ± SD. *, P<0.05; **, P<0.01, compared with the blank group. MMP9, matrix metallopeptidase 9; IL-8, interleukin-8; HCCLM6, hepatocellular carcinoma LM6; PKC, protein kinase C; ERK1/2, extracellular regulated protein kinases 1/2; SD, standard deviation.

Article Snippet: To evaluate the effects of protein kinase C (PKC) inhibitors (HY-12048, MedChemExpress, USA) and ERK1/2 inhibitors (HY-12028, MedChemExpress, USA) on tumor metastasis in an orthotopic implantation mouse model of HCC, the mice were divided into 3 groups with 7 mice in each group.

Techniques: Expressing, Western Blot, Control, Standard Deviation

Effects of PKC and ERK1/2 inhibitors on pro-colonization induced by IL-8 in the orthotopically implanted mice. (A) Representative images of live tissues in the orthotopically implanted mice that were treated with PKC and ERK1/2 inhibitors. (B) Hematoxylin/eosin-stained images and the number of metastases of liver or lung tissues isolated from the PKC and ERK1/2 inhibitors treated mice as indicated. Scale bars =400 µm. (C) MMP9 expression of live tissues was measured by qRT-PCR in PKC and ERK1/2 inhibitors-treated orthotopically implanted mice. (D) MMP9 expression of live tissues was measured by immunohistochemical staining in PKC and ERK1/2 inhibitors-treated orthotopically implanted mice. Scale bars =100 µm. Data are presented as mean ± SD. *, P<0.05; **, P<0.01, compared with the IL-8 group. PKC, protein kinase C; ERK1/2, extracellular regulated protein kinases 1/2; IL-8, interleukin-8; IOD, integral optical density; MMP9, matrix metallopeptidase 9; qRT-PCR, quantitative real-time polymerase chain reaction; SD, standard deviation.

Journal: Translational Cancer Research

Article Title: Effect of IL-8 on hepatocellular carcinoma-associated metastasis by targeting MMP9 in mice

doi: 10.21037/tcr-22-37

Figure Lengend Snippet: Effects of PKC and ERK1/2 inhibitors on pro-colonization induced by IL-8 in the orthotopically implanted mice. (A) Representative images of live tissues in the orthotopically implanted mice that were treated with PKC and ERK1/2 inhibitors. (B) Hematoxylin/eosin-stained images and the number of metastases of liver or lung tissues isolated from the PKC and ERK1/2 inhibitors treated mice as indicated. Scale bars =400 µm. (C) MMP9 expression of live tissues was measured by qRT-PCR in PKC and ERK1/2 inhibitors-treated orthotopically implanted mice. (D) MMP9 expression of live tissues was measured by immunohistochemical staining in PKC and ERK1/2 inhibitors-treated orthotopically implanted mice. Scale bars =100 µm. Data are presented as mean ± SD. *, P<0.05; **, P<0.01, compared with the IL-8 group. PKC, protein kinase C; ERK1/2, extracellular regulated protein kinases 1/2; IL-8, interleukin-8; IOD, integral optical density; MMP9, matrix metallopeptidase 9; qRT-PCR, quantitative real-time polymerase chain reaction; SD, standard deviation.

Article Snippet: To evaluate the effects of protein kinase C (PKC) inhibitors (HY-12048, MedChemExpress, USA) and ERK1/2 inhibitors (HY-12028, MedChemExpress, USA) on tumor metastasis in an orthotopic implantation mouse model of HCC, the mice were divided into 3 groups with 7 mice in each group.

Techniques: Staining, Isolation, Expressing, Quantitative RT-PCR, Immunohistochemical staining, Real-time Polymerase Chain Reaction, Standard Deviation

A and B, Activin and myostatin levels of mRNA expression in eight paired fibroid and myometrial specimens. C–F, Levels of mRNA expression in eight paired fibroid and myometrial specimens for the four receptor genes ALK4, ALK5, ActRII, and ActRIIB. Graphs on column I are line graphs linking paired specimens, and those on column II are box-and-whisker plots. In column III is reported the correlation of activin-A with its receptors, whereas in column IV is reported the correlation of myostatin with its receptors. The nonparametric correlation (Spearman) revealed no correlation of both activin and myostatin levels with receptor levels. *, P < 0.05.

Journal: The Journal of Clinical Endocrinology and Metabolism

Article Title: Activin-A and Myostatin Response and Steroid Regulation in Human Myometrium: Disruption of Their Signalling in Uterine Fibroid

doi: 10.1210/jc.2010-0501

Figure Lengend Snippet: A and B, Activin and myostatin levels of mRNA expression in eight paired fibroid and myometrial specimens. C–F, Levels of mRNA expression in eight paired fibroid and myometrial specimens for the four receptor genes ALK4, ALK5, ActRII, and ActRIIB. Graphs on column I are line graphs linking paired specimens, and those on column II are box-and-whisker plots. In column III is reported the correlation of activin-A with its receptors, whereas in column IV is reported the correlation of myostatin with its receptors. The nonparametric correlation (Spearman) revealed no correlation of both activin and myostatin levels with receptor levels. *, P < 0.05.

Article Snippet: All results were normalized against either β-actin and hypoxanthine-guanine phosphoribosyl transferase expression to correct for differences in concentration of the starting template. table ft1 table-wrap mode="anchored" t5 Table 1. caption a7 Gene name Alias Gene symbol Reference sequence Assay ID Amplicon length Inhibin, βA EDF INHBA {"type":"entrez-nucleotide","attrs":{"text":"NM_002192.2","term_id":"62953137","term_text":"NM_002192.2"}} NM_002192.2 Hs00170103_m1 61 FRP Follistatin-like 3 (secreted glycoprotein) FLRG FSTL3 {"type":"entrez-nucleotide","attrs":{"text":"NM_005860.2","term_id":"95104789","term_text":"NM_005860.2"}} NM_005860.2 Hs00610505_m1 84 FSRP Actin, β PS1TP5BP1 ACTB {"type":"entrez-nucleotide","attrs":{"text":"NM_001101.3","term_id":"168480144","term_text":"NM_001101.3"}} NM_001101.3 Hs99999903_m1 171 Myostatin GDF8 MSTN {"type":"entrez-nucleotide","attrs":{"text":"NM_005259.2","term_id":"149408158","term_text":"NM_005259.2"}} NM_005259.2 Hs00193363_m1 118 Activin-A receptor, type IIA ACTRII ACVR2A {"type":"entrez-nucleotide","attrs":{"text":"NM_001616.3","term_id":"65508448","term_text":"NM_001616.3"}} NM_001616.3 Hs01012007_m1 110 ACVR2 Activin-A receptor, type IB ACTRIB AcvR1B {"type":"entrez-nucleotide","attrs":{"text":"NM_004302.3","term_id":"33598913","term_text":"NM_004302.3"}} NM_004302.3 Hs00923299_m1 74 ACVRLK4 ALK4 SKR2 TGF, β receptor 1 AAT5 TGFBR1 {"type":"entrez-nucleotide","attrs":{"text":"NM_004612.2","term_id":"66346739","term_text":"NM_004612.2"}} NM_004612.2 Hs00610318_m1 92 ACVRLK4 ALK-5 ALK5 LDS1A LDS2A SKR4 TGFR-1 Follistatin FS FST {"type":"entrez-nucleotide","attrs":{"text":"NM_006350.2","term_id":"7242223","term_text":"NM_006350.2"}} NM_006350.2 Hs00246260_m1 105 Hypoxanthine phosphoribosyltransferase 1 HGPRT HPRT1 {"type":"entrez-nucleotide","attrs":{"text":"NM_000194.2","term_id":"164518913","term_text":"NM_000194.2"}} NM_000194.2 Hs99999909_m1 100 HPRT Activin-A receptor, type IIB ACTRIIB ACVR2B {"type":"entrez-nucleotide","attrs":{"text":"NM_001106.3","term_id":"116734707","term_text":"NM_001106.3"}} NM_001106.3 Hs00609603_m1 101 ActR-IIB MGC116908 Cripto, FGF receptor-like-1, cryptic family 1 CFC1 CRYPTIC {"type":"entrez-nucleotide","attrs":{"text":"NM_032545.2","term_id":"24234758","term_text":"NM_032545.2"}} NM_032545.2 Hs00414425_m1 90 FLJ77897 HTX2 MGC133213 SMAD family member 7 SMAD7 CRCS3 {"type":"entrez-nucleotide","attrs":{"text":"NM_005904.2","term_id":"52856403","term_text":"NM_005904.2"}} NM_005904.2 Hs00178696_m1 61 FLJ16482 MADH7 MADH8 Open in a separate window TaqMan gene expression assays (Applied Biosystems) used to perform the real-time PCR

Techniques: Expressing, Whisker Assay

TaqMan gene expression assays (Applied Biosystems) used to perform the real-time PCR

Journal: The Journal of Clinical Endocrinology and Metabolism

Article Title: Activin-A and Myostatin Response and Steroid Regulation in Human Myometrium: Disruption of Their Signalling in Uterine Fibroid

doi: 10.1210/jc.2010-0501

Figure Lengend Snippet: TaqMan gene expression assays (Applied Biosystems) used to perform the real-time PCR

Article Snippet: All results were normalized against either β-actin and hypoxanthine-guanine phosphoribosyl transferase expression to correct for differences in concentration of the starting template. table ft1 table-wrap mode="anchored" t5 Table 1. caption a7 Gene name Alias Gene symbol Reference sequence Assay ID Amplicon length Inhibin, βA EDF INHBA {"type":"entrez-nucleotide","attrs":{"text":"NM_002192.2","term_id":"62953137","term_text":"NM_002192.2"}} NM_002192.2 Hs00170103_m1 61 FRP Follistatin-like 3 (secreted glycoprotein) FLRG FSTL3 {"type":"entrez-nucleotide","attrs":{"text":"NM_005860.2","term_id":"95104789","term_text":"NM_005860.2"}} NM_005860.2 Hs00610505_m1 84 FSRP Actin, β PS1TP5BP1 ACTB {"type":"entrez-nucleotide","attrs":{"text":"NM_001101.3","term_id":"168480144","term_text":"NM_001101.3"}} NM_001101.3 Hs99999903_m1 171 Myostatin GDF8 MSTN {"type":"entrez-nucleotide","attrs":{"text":"NM_005259.2","term_id":"149408158","term_text":"NM_005259.2"}} NM_005259.2 Hs00193363_m1 118 Activin-A receptor, type IIA ACTRII ACVR2A {"type":"entrez-nucleotide","attrs":{"text":"NM_001616.3","term_id":"65508448","term_text":"NM_001616.3"}} NM_001616.3 Hs01012007_m1 110 ACVR2 Activin-A receptor, type IB ACTRIB AcvR1B {"type":"entrez-nucleotide","attrs":{"text":"NM_004302.3","term_id":"33598913","term_text":"NM_004302.3"}} NM_004302.3 Hs00923299_m1 74 ACVRLK4 ALK4 SKR2 TGF, β receptor 1 AAT5 TGFBR1 {"type":"entrez-nucleotide","attrs":{"text":"NM_004612.2","term_id":"66346739","term_text":"NM_004612.2"}} NM_004612.2 Hs00610318_m1 92 ACVRLK4 ALK-5 ALK5 LDS1A LDS2A SKR4 TGFR-1 Follistatin FS FST {"type":"entrez-nucleotide","attrs":{"text":"NM_006350.2","term_id":"7242223","term_text":"NM_006350.2"}} NM_006350.2 Hs00246260_m1 105 Hypoxanthine phosphoribosyltransferase 1 HGPRT HPRT1 {"type":"entrez-nucleotide","attrs":{"text":"NM_000194.2","term_id":"164518913","term_text":"NM_000194.2"}} NM_000194.2 Hs99999909_m1 100 HPRT Activin-A receptor, type IIB ACTRIIB ACVR2B {"type":"entrez-nucleotide","attrs":{"text":"NM_001106.3","term_id":"116734707","term_text":"NM_001106.3"}} NM_001106.3 Hs00609603_m1 101 ActR-IIB MGC116908 Cripto, FGF receptor-like-1, cryptic family 1 CFC1 CRYPTIC {"type":"entrez-nucleotide","attrs":{"text":"NM_032545.2","term_id":"24234758","term_text":"NM_032545.2"}} NM_032545.2 Hs00414425_m1 90 FLJ77897 HTX2 MGC133213 SMAD family member 7 SMAD7 CRCS3 {"type":"entrez-nucleotide","attrs":{"text":"NM_005904.2","term_id":"52856403","term_text":"NM_005904.2"}} NM_005904.2 Hs00178696_m1 61 FLJ16482 MADH7 MADH8 Open in a separate window TaqMan gene expression assays (Applied Biosystems) used to perform the real-time PCR

Techniques: Expressing, Sequencing, Amplification